The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
The dried leaves, flowers, stems, and seeds of the cannabis sativa or cannabis indica plant are referred as cannabis. Tetrahydrocannabinol (THC) as well as other mind-altering chemicals which are psychoactive substances such as cannabidiol are found in the plants such... View more
U.S. Sucralfate Market – Market Insights Sucralfate is the generic form of the brand-name drug, Carafate. It is a prescription medicine used to treat ulcers of the upper gastrointestinal tract, peptic ulcer di... View more
Global Lyophilized Drugs Market Insights Lyophilization of the sterile injectable is necessary to maintain the stability of some unstable bulk ingredients. Lyophilization provides long... View more
Cephalosporin is a large group of antibiotics that belongs to a class known as beta-lactams. Cephalosporin is a wide spectrum bactericidal antibiotic used for the treatment of several bacterial infections. Cephalosporin drugs are available as both branded and generic ... View more
Diabetes nutrition is used by people with diabetes mellitus or high blood sugar to reduce the symptoms and dangerous complications of diabetes. Diabetes nutrition include proteins, amino acids, omega-3 fatty acids, alpha-lipoic acid, herbal supplements, soluble fiber,... View more
Glycine is the simplest amino acid, which is colorless and sweet-tasting crystalline solid. It is insoluble in ethanol and ethyl ether whereas it is moderately soluble in acetone. It helps in healthy functioning of kidney and liver, as it is naturally available in abu... View more
Global Outsourced Drug Discovery Market Insights Outsourcing is a strategy, by which a pharmaceutical company hires another company such as contract research organization for planned and existing activities including ... View more
Sirolimus is a macrolide compound also known as rapamycin, which is a potent immunosuppressant and shows both antifungal and antineoplastic properties. It works by weakening the immune system, and helps your body to accept the new organ, so in this manner it helps in ... View more
The global ferrous fumarate market size is expected to witness potential gains in the future, and register a significant CAGR of 15.74% over the forecast period (2019 - 2027). Market Overview ... View more
The global anti-obesity drug market was valued at US$ 1,897.5 Mn in 2021 and is forecast to reach a value of US$ 5,392.4 Mn by 2028 at a CAGR of 16.1% between&n... View more
Hemoglobinopathy a group of hereditary blood disorders involving an abnormality in the structure of hemoglobin. . These disorders include both sickle cell disease (SCD) and thalassemia. Common symptoms of the condition include, severe pain, shortness of breath, enlarg... View more
Hyperhidrosis is a condition where in a person experiences an excessive sweating. It mainly affects the facial area, hands, feet, and armpit. The sweating is either localized, i.e., the sweating will occur in a particular area or generalized. It further has two subtyp... View more
Nasal polyps are soft, painless, noncancerous developments on the coating of nasal sections or sinuses. They hang down like grapes and are in yellowish brown or pink color. They result from persistent irritation and are related with asthma, repeating disease, sensitiv... View more
Sarcopenia means loss of skeletal muscle mass or loss of flesh by aging. Sarcopenia is associated with functional impairments in tasks such as standing up from a chair or lifting 10 pounds and physical disabilities such as not able to perform home chores and personal ... View more
Silver sulfadiazine is specifically used for second degree or third-degree burns on the skin, which acts ant-bacterial drug. The World Health Organization considers silver sulfadiazine as an Essential Medicines and is used as an antibiotic for skin burns. Silver sulfa... View more
Cancer is a chronic condition that involves abnormal growth of cell. Interference due to genetic changes causes uncontrollable growth of cells and results into formation of a mass called tumor. The tumor is malignant type, it is capable to spread all over the body. Mo... View more
Regulatory Affairs Outsourcing Market – Insights Regulatory affairs outsourcing are the services utilized by the pharmaceutical, biotech and medical devices manufacturing companies for gaining fast regu... View more
Cardiovascular diseases remain a leading cause of mortality and morbidity worldwide. The development of peptide as therapeutic agent has been avoided by pharmaceutical industry due to its low stability, size, degradation rate, and poor stability. However, recently, re... View more